Evidence supporting the use of: Vitamin E (mixed tocopherols)
For the health condition: Dementia

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E (specifically as mixed tocopherols) has been studied for its potential to support or slow the progression of dementia, particularly Alzheimer’s disease, due to its antioxidant properties. The scientific rationale is based on the hypothesis that oxidative stress contributes to neuronal damage in dementia, and antioxidants like vitamin E could help mitigate this damage. Some clinical trials have been conducted, most notably a 1997 study published in the New England Journal of Medicine (Sano et al.), which found that high-dose alpha-tocopherol (2000 IU/day) modestly delayed clinical progression in patients with moderate Alzheimer’s disease. Later studies, such as the 2014 TEAM-AD VA Cooperative Study, showed a small benefit in slowing functional decline but found no significant effect on cognitive outcomes. Additionally, some meta-analyses and reviews have concluded that while there may be a mild effect on symptom progression, the evidence is not robust or consistent, and high doses of vitamin E may be associated with increased risk of adverse events such as hemorrhagic stroke or all-cause mortality. The use of mixed tocopherols (rather than just alpha-tocopherol) is less well-studied. Major guidelines do not recommend routine use of vitamin E for dementia, but its use is occasionally considered as adjunctive therapy. In summary, there is limited scientific support for vitamin E in dementia, with modest benefits and potential risks.

More about Vitamin E (mixed tocopherols)
More about Dementia

Products containing Vitamin E (mixed tocopherols)

We currently have no products on Vitabase that contain this ingredient.